Public knowledge and beliefs about the irritable bowel syndrome - results from the SOMA.SOC study

被引:1
|
作者
von dem Knesebeck, Olaf [1 ]
Loewe, Bernd [2 ]
Luedecke, Daniel [1 ]
Bobardt, Johanna S. [3 ]
Barbek, Rieke [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf UKE, Inst Med Sociol, Martinstr 52, D-20246 Hamburg, Germany
[2] UKE, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany
[3] UKE, Dept Gen Practice & Primary Care, Hamburg, Germany
关键词
Irritable bowel syndrome; Knowledge; Beliefs; Health literacy; SOMA.SOC; DEPRESSION LITERACY; GLOBAL PREVALENCE; HEALTH LITERACY; GASTROENTEROLOGY; MANAGEMENT; DIAGNOSIS; SOCIETY;
D O I
10.1186/s12889-024-17784-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundDespite the epidemiological and economic relevance of the irritable bowel syndrome (IBS), there is a lack of research on what the general public knows and thinks about this condition (IBS literacy). Therefore, the aim of this study was to explore public knowledge and beliefs about IBS in Germany. Moreover, associations of knowledge and beliefs about IBS with socio-demographic characteristics as well as illness and treatment experiences were analysed.MethodsAnalyses made use of a national telephone survey (N = 1,205). A carefully developed vignette describing a person with typical symptoms of IBS was presented. Respondents were then asked to name the disease in question and beliefs about causes and treatment options were assessed. For the analyses respondents were divided into three groups: (1) people who never had IBS symptoms, (2) people who had or have IBS symptoms but never were in treatment and (3) individuals who reported to be or have been treated for IBS symptoms.ResultsLess than 4% of the respondents recognized IBS after presentation of the vignette. About 75% positively evaluated treatability while psychotherapy was evaluated more effective than medication. Stress and unhealthy lifestyle were the most frequently endorsed possible causes of the presented IBS symptoms. There were variations in knowledge and beliefs about IBS according to age, gender, and education. We found minor differences in beliefs and knowledge between individuals who had or have symptoms but never were in treatment and those without respective illness experience. Respondents with illness/treatment experiences rated their knowledge significantly better than those without any experiences.ConclusionsResults indicate low levels of public knowledge about IBS regarding illness recognition in Germany. A majority disagreed that they have good knowledge about IBS symptoms. Against this background, it seems reasonable to develop and test interventions to improve IBS literacy by increasing knowledge about symptoms, causes and treatment options.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case-control study
    Staller, Kyle
    Olen, Ola
    Soderling, Jonas
    Roelstraete, Bjorn
    Tornblom, Hans
    Kuo, Braden
    Nguyen, Long H.
    Ludvigsson, Jonas F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1175 - 1184
  • [32] BUILDING CLINICAL IRRITABLE BOWEL SYNDROME PHENOTYPES: RESULTS FROM A LARGE SURVEY FROM ARGENTINA
    Pereyra, Facu
    Pereyra, Lisandro
    Steinberg, Leandro H.
    Lasa, Juan S.
    GASTROENTEROLOGY, 2023, 164 (06) : S1068 - S1068
  • [33] Impact of Age on Beliefs About and Adherence to Medications in Patients With Inflammatory Bowel Disease: Results From the ALIGN Study
    Michetti, Pierre F.
    Peyrin-Biroulet, Laurent
    Silverberg, Mark S.
    Louis, Edouard
    Weinman, John
    Sommer, Julia
    Petersson, Joel H.
    Pappalardo, Brandee
    Nurwakagari, Pascal
    GASTROENTEROLOGY, 2016, 150 (04) : S790 - S791
  • [34] Effect of age on beliefs about and adherence to medications in patients with inflammatory bowel disease: results from the ALIGN study
    Michetti, P.
    Peyrin-Biroulet, L.
    Silverberg, M. S.
    Louis, E.
    Weinman, J.
    Sommer, J.
    Petersson, J.
    Pappalardo, B.
    Nurwakagari, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S253 - S254
  • [35] Predictors of work productivity in irritable bowel syndrome (IBS): Results from the proof cohort
    Spiegel, Brennan M.
    Harris, Lucinda A.
    Lucak, Susan L.
    Mayer, Emeran A.
    Naliboff, Bruce D.
    Bolus, Roger E.
    Esrailian, Eric
    Chey, William D.
    Lembo, Anthony
    Karsan, Hetal A.
    Tillisch, Kirsten
    Dulai, Gareth S.
    Strickland, Amy
    Chang, Lin
    GASTROENTEROLOGY, 2008, 134 (04) : A28 - A28
  • [36] Knowledge, Awareness, and Prevalence of Irritable Bowel Syndrome in the Saudi Community: A Cross-Sectional Study
    Baig, Mukhtiar
    Gazzaz, Zohair J.
    Alyoubi, Wedyan E.
    Almaslamani, Norah W.
    Albaqami, Shada M.
    Almalki, Rawan A.
    Althikra, Abdulaziz H.
    Alosaimi, Sarah A.
    Alzahrani, Khames T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [37] Predictive study of academic stress with the irritable bowel syndrome in medicine students at a public university in Mexico
    Pozos-Radillo, Elizabeth
    Preciado-Serrano, Lourdes
    Plascencia-Campos, Ana
    Morales-Fernandez, Armando
    Valdez-Lopez, Rosa
    LIBYAN JOURNAL OF MEDICINE, 2018, 13
  • [38] Prevalence of irritable bowel syndrome: a community based study from North India
    Makharia, G. K.
    Verma, A. K.
    Amarchand, R.
    Goswami, A.
    Anand, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A74 - A74
  • [39] Effect of stool consistency on bowel movement satisfaction in patients with Irritable Bowel Syndrome with constipation or chronic idiopathic constipation: results from the CONTOR study
    Taylor, D. C. A.
    Abel, J. L.
    Doshi, J. A.
    Martin, C.
    Hunter, A. Goolsby
    Essoi, B.
    Korrer, S.
    Carson, R. T.
    Reasner, D. S.
    Chey, W. D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [40] Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
    Daniel Keszthelyi
    Gwen H Dackus
    Gwen M Masclee
    Joanna W Kruimel
    Ad AM Masclee
    BMC Gastroenterology, 12